Mutations in epigenetic regulators in myelodysplastic syndromes.
about
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutationsDetection of acquired hemoglobinopathy in children with hematological malignancies at disease onset: results form a national referral centre.The molecular basis of myeloid malignancies.Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cellsPulmonary Complications of Azanucleoside Therapy in Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia.Digging deep into "dirty" drugs - modulation of the methylation machinery.Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblastsAge-related epigenetic drift in the pathogenesis of MDS and AML.Epigenetic aspects of MDS and its molecular targeted therapy.The myelodysplastic syndromes: the era of understanding.The molecular pathogenesis of the myelodysplastic syndromes.Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability.Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies.[Myelodysplastic syndromes. Epidemiology, molecular and morphological characteristics and risk stratification].The Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants.Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine.DNA Methylation and Adult Neurogenesis.
P2860
Q28590040-A0DA638F-67C5-4F2A-B810-30BB2491AEF6Q34375577-D650782A-037B-4D4A-84AD-9108B470242EQ35103708-F420CEB3-CDEC-4382-B99E-C09B2A4AD25DQ36141856-4E3B6B3F-4568-4ABD-AE92-E1B4ED56FD66Q36422867-BCF4C269-FB49-4CCE-BFCF-13712980FA0EQ36523796-E27CA1FD-B7AC-49AA-82F9-44D4AFDCCFCDQ36936451-E4A1E163-B2D2-42FF-9087-F16FF4392C74Q37683456-5A9AF947-1E8C-4409-A9E1-A47B749B2AE6Q38051195-029F82F6-8ABE-4A2F-AD19-DD6BD9B1AEB7Q38245878-45896436-8053-435F-AEAF-1083DAF651D1Q38341998-ABFB4A1A-2217-489B-9013-05DF5C0842D1Q38683360-8B06E4E4-649A-40F7-91AE-7090527AB810Q41135028-52FB27B4-543D-4BE5-8369-0DA509A2E99AQ44325617-DE4B2BEA-64AE-4525-8798-8DFA3F627419Q53160146-4705F768-2DEA-4BC2-B623-CD52A8523F1EQ53820609-81CB9732-8F77-4CD1-A0A7-C5E49E8DFC29Q55285000-EC74F7E9-8817-4D52-BF15-1AC7D8F91681
P2860
Mutations in epigenetic regulators in myelodysplastic syndromes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mutations in epigenetic regulators in myelodysplastic syndromes.
@en
Mutations in epigenetic regulators in myelodysplastic syndromes.
@nl
type
label
Mutations in epigenetic regulators in myelodysplastic syndromes.
@en
Mutations in epigenetic regulators in myelodysplastic syndromes.
@nl
prefLabel
Mutations in epigenetic regulators in myelodysplastic syndromes.
@en
Mutations in epigenetic regulators in myelodysplastic syndromes.
@nl
P2093
P2860
P1476
Mutations in epigenetic regulators in myelodysplastic syndromes.
@en
P2093
Bert A van der Reijden
Gorica Nikoloski
Joop H Jansen
P2860
P2888
P356
10.1007/S12185-011-0996-3
P577
2012-01-11T00:00:00Z